Independent Advisor Alliance’s VanEck Pharmaceutical ETF PPH Stock Holding History

Independent Advisor Alliance’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-55,078	Closed	-$4.98M	–	1047
2025 Q3	$4.98M	Buy	55,078 +3,559	+7%	+$312K	0.13%	134
2025 Q2	$4.53M	Buy	51,519 +5,207	+11%	+$451K	0.13%	125
2025 Q1	$4.22M	Sell	46,312 -12,086	-21%	-$1.09M	0.14%	126
2024 Q4	$5.04M	Buy	58,398 +9,647	+20%	+$873K	0.07%	265
2024 Q3	$4.63M	Sell	48,751 -245	-0.5%	-$23.3K	0.17%	107
2024 Q2	$4.48M	Sell	48,996 -264	-0.5%	-$23.6K	0.15%	115
2024 Q1	$4.47M	Sell	49,260 -49,213	-50%	-$4.31M	0.16%	112
2023 Q4	$7.94M	Buy	98,473 +49,423	+101%	+$3.88M	0.29%	63
2023 Q3	$3.92M	Buy	+49,050	New	+$3.96M	0.18%	105

Other funds holding PPH

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Independent Advisor Alliance's PPH Position: Q4 2025 in Review

Independent Advisor Alliance sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2025, closing a stake of 55,078 shares — an estimated $4.98M sold.

Independent Advisor Alliance first reported a position in PPH in Q3 2023 and held it in 9 quarters. The position peaked at $7.94M in Q4 2023. 146 funds tracked by Wall St. Rank hold PPH as of Q4 2025.

Independent Advisor Alliance reported no remaining VanEck Pharmaceutical ETF position as of Q4 2025 after selling out during the quarter.
Independent Advisor Alliance sold 55,078 VanEck Pharmaceutical ETF shares in Q4 2025, an estimated $4.98M.
Independent Advisor Alliance first reported a position in VanEck Pharmaceutical ETF in Q3 2023 and held it in 9 quarters.
Independent Advisor Alliance's VanEck Pharmaceutical ETF position peaked at $7.94M in Q4 2023.
146 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2025.

Based on Independent Advisor Alliance's 13F filing for Q4 2025, filed 4 Feb 2026.